Corrigendum to "Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years" [Vaccine 35 (2017) 1254-1258].

Baxter, Roger; Eaton, Abigail; Hansen, John; Aukes, Laurie; Caspard, Herve; Ambrose, Christopher S.

Afiliação

Baxter R; Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, Ordway Building, 16th Floor, Oakland, CA 94612, United States.
Eaton A; Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, Ordway Building, 16th Floor, Oakland, CA 94612, United States.
Hansen J; Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, Ordway Building, 16th Floor, Oakland, CA 94612, United States. Electronic address: john.hansen@kp.org.
Aukes L; Kaiser Permanente Vaccine Study Center, 1 Kaiser Plaza, Ordway Building, 16th Floor, Oakland, CA 94612, United States.
Caspard H; AstraZeneca, One MedImmune Way, Gaithersburg, MD 20878, United States.
Ambrose CS; AstraZeneca, One MedImmune Way, Gaithersburg, MD 20878, United States.

Vaccine ; 35(23): 3152, 2017 05 25.

Article em En | MEDLINE | ID: mdl-28457674

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article